Detalles de la búsqueda
1.
Preoperative MRI radiomic analysis for predicting local tumor progression in colorectal liver metastases before microwave ablation.
Int J Hyperthermia;
41(1): 2349059, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38754994
2.
Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
Eur Radiol;
32(6): 4147-4159, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092474
3.
Tailoring the radiotherapy approach in patients with anal squamous cell carcinoma based on inguinal sentinel lymph node biopsy.
J Surg Oncol;
123(1): 315-321, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32964456
4.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol;
21(4): 497-507, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164906
5.
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.
Oncologist;
25(6): e928-e935, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943506
6.
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
N Engl J Med;
371(17): 1609-18, 2014 Oct 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25337750
7.
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
BMC Cancer;
17(1): 408, 2017 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28599628
8.
Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients.
Oncology;
91(5): 283-288, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27577551
9.
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.
Lancet Oncol;
16(13): 1306-15, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26338525
10.
Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer.
Future Oncol;
10(6): 975-83, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24295376
11.
Immunotherapy in small bowel adenocarcinoma: a potential role?
Immunol Med;
47(1): 1-5, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37293784
12.
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study.
Eur J Cancer;
182: 87-97, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36753836
13.
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation.
J Clin Oncol;
41(34): 5263-5273, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37535876
14.
Evolution of Surgical Treatment of Colorectal Liver Metastases in the Real World: Single Center Experience in 1212 Cases.
Cancers (Basel);
13(5)2021 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33803257
15.
Small EVs-Associated DNA as Complementary Biomarker to Circulating Tumor DNA in Plasma of Metastatic Colorectal Cancer Patients.
Pharmaceuticals (Basel);
14(2)2021 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33562158
16.
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial.
Eur J Cancer;
148: 190-201, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33744715
17.
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study.
J Immunother Cancer;
9(11)2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34815354
18.
Assessing the impact of COVID-19 on liver cancer management (CERO-19).
JHEP Rep;
3(3): 100260, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33644725
19.
Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients.
Sci Rep;
10(1): 14613, 2020 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32884036
20.
Changes in body composition during neoadjuvant therapy can affect prognosis in rectal cancer patients: An exploratory study.
Curr Probl Cancer;
44(2): 100510, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31703987